Workforce management in real-time for healthcare industries
Post-money valuation โ
$16.9M
As of Dec 2023 ยท from Reg CF Offering (2023) ยท pre-money + amount raised, not a traded price
Total raised
$776,507
Across 2 rounds since 2020
Latest share price
$7.91
Reg CF Offering (2023) offering price
Financials
FY2018โFY2025 ยท from SEC filings ยท hover any figure for its source
$0
โ$186K
2018
$37K
โ$680K
2019
$37K
โ$680K
2020
$1.1M
โ$1.3M
2021
$4.8M
โ$2.1M
2022
$8.5M
โ$316K
2023
$14.4M
$218K
2024
$16.7M
$184K
2025
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$37,464
$37,464
$1,113,087
$4,789,416
$8,521,913
$14,425,816
$16,668,031
Cost of goods sold
$0
$0
$0
$0
$24,207
$5,568
$1,769
$0
Gross margin
โ
100%
100%
100%
99%
100%
100%
100%
Net income
-$186,404
-$680,297
-$680,297
-$1,326,564
-$2,071,531
-$316,140
$217,835
$184,352
Taxes paid
$0
$0
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$54,962
$37,482
$37,482
$199,102
$291,785
$215,520
$497,079
$914,122
Accounts receivable
$0
$0
$0
$212,825
$0
$317,416
$568,764
$287,564
Total assets
$55,013
$51,405
$51,405
$732,745
$770,018
$727,470
$2,670,970
$1,639,901
Short-term debt
$51,686
$143,636
$143,636
$405,621
$4,100,105
$1,085,335
$1,527,045
$2,358,874
Long-term debt
$181,598
$675,000
$67,500
$2,905,142
$770,018
-$357,865
$1,519,133
$197,355
Total liabilities
$233,284
$818,636
$211,136
$3,310,763
$4,870,123
$727,470
$3,046,178
$2,556,229
Other
Headcount
โ
1
2
5
1
3
3
3
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.